Anthony V. D'Amico, MD, PhD, discusses Gleason score interpretation in the management of localized prostate cancer.
Anthony V. D'Amico, MD, PhD
Advertisement
Articles by Anthony V. D'Amico, MD, PhD
Anthony V. D'Amico, MD, PhD, discusses the Decipher Genomic Classifier in prostate cancer treatment.
Anthony V. D'Amico, MD, PhD, on the advancements in high-risk prostate cancer diagnosis and management
Advertisement
Latest Updated Articles
Dr D’Amico on Genomic Classifiers in Prostate CancerPublished: June 5th 2024 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5